Interaction of Nanoparticles with Blood Components and Associated Pathophysiological Effects
Open Access
- 21 March 2018
- book chapter
- Published by IntechOpen
Abstract
Nanotechnology currently plays a pivotal role in several fields and has enabled substantial advances in a relatively short time. In biomedicine, nanomaterials can be potentially employed as a tool for early diagnosis and an innovative mode of drug delivery. Novel nanomaterials are currently widely manipulated without a full assessment of their potential health risks. It is commonly thought that nanomaterials’ first contact with the organism is through the different components of the immune system. However, if the entry route is intravenous, the first contact will be with the blood’s components (erythrocytes, platelets, white cells, plasma and complement proteins). The presence of nanomaterials within a dynamic environment such as the bloodstream can produce potential harmful effects following interaction with several blood components. The design of innovative strategies leading to the development of more hemocompatible nanomaterials is also necessary.Keywords
This publication has 120 references indexed in Scilit:
- In-flight gas phase growth of metal/multi layer graphene core shell nanoparticles with controllable sizesScientific Reports, 2013
- Biomaterials-Based Modulation of the Immune SystemBioMed Research International, 2013
- Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticleJournal of Nanobiotechnology, 2013
- EGFP-EGF1-Conjugated PLGA Nanoparticles for Targeted Delivery of siRNA into Injured Brain Microvascular Endothelial Cells for Efficient RNA InterferencePLOS ONE, 2013
- Systematic safety evaluation on photoluminescent carbon dotsDiscover Nano, 2013
- Variable Antibody-dependent Activation of Complement by Functionalized Phospholipid Nanoparticle SurfacesJournal of Biological Chemistry, 2011
- Effects of 45-nm silver nanoparticles on coronary endothelial cells and isolated rat aortic ringsToxicology Letters, 2009
- Factors modulating the delivery and effect of enzymatic cargo conjugated with antibodies targeted to the pulmonary endotheliumJournal of Controlled Release, 2007
- Physicochemical and Biological Characterization of Targeted, Nucleic Acid-Containing NanoparticlesBioconjugate Chemistry, 2007
- Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticlesProceedings of the National Academy of Sciences, 2007